ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,435Medicare Part D Prescriptions Filled, Including Refills

Rank: 188 out of 617

$416K Total Retail Price of All Prescriptions

Rank: 145 out of 617

353 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 353 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 353 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 5,583 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 380 334 1 1
HYDROCODONE-ACETAMINOPHEN 260 179 S3 2 8
SIMVASTATIN 243 206 3 2
OMEPRAZOLE 234 140 4 3
METOPROLOL SUCCINATE 226 184 5 12
FUROSEMIDE 202 177 6 4
WARFARIN SODIUM 181 138 7 7
METFORMIN HCL 164 103 8 9
CARVEDILOL 162 153 9 19
CITALOPRAM HBR 158 143 10 18
AMLODIPINE BESYLATE 150 138 11 6
ATORVASTATIN CALCIUM 134 91 12 14
LISINOPRIL 134 133 12 5
GABAPENTIN 120 97 14 16
BENAZEPRIL HCL 112 90 15 44
FLUTICASONE PROPIONATE 109 92 16 36
KLOR-CON 10 102 80 17 126
LOSARTAN POTASSIUM 96 87 18 22
TRAMADOL HCL 74 56 19 15
PREDNISONE 71 58 20 31
ZOLPIDEM TARTRATE 71 56 20 23
LANTUS SOLOSTAR 70 31 22 115
LYRICA 68 18 23 92
MELOXICAM 66 53 24 24
TRAZODONE HCL 65 16 25 51
ALENDRONATE SODIUM 59 59 26 25
ATENOLOL 57 50 27 17
CRESTOR 55 38 28 28
ROPINIROLE HCL 54 23 29 66
SERTRALINE HCL 54 49 29 20
VESICARE 53 46 31 95
NOVOLOG FLEXPEN 53 34 31 203
LEVOFLOXACIN 53 36 31 89
DONEPEZIL HCL 53 53 31 30
DIGOXIN 51 51 35 48
PANTOPRAZOLE SODIUM 51 47 35 37
OXYCODONE-ACETAMINOPHEN 50 13 S2 37 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.